The Scottish Huntington’s Association has welcomed the breakthrough in Huntington’s disease research that could see treatment for the condition to stop, and even reverse its progression.
For the first time a drug has lowered the amount of faulty protein that is known to cause Huntington’s Disease. An experimental drug, injected into spinal fluid, has safely lowered levels of toxic proteins in the brain that cause the disease.
The research team, at University College London, say there is now hope the deadly disease can be stopped. Experts say it could be the biggest breakthrough in neurodegenerative diseases for 50 years.
SHA chief executive John Eden said that Scottish patients and scientists will likely be involved in the next trial.
‘This is absolutely a momentous breakthrough. It is the first drug shown to directly address the root cause of Huntington’s – the production of the faulty Huntington protein. That’s never been done before.
‘It is the moment that families have waited for since the genetic change that causes HD was identified in 1993. For them it has been an impossibly long wait, but this historic announcement makes intangible hope, tangible progress.’